Vitamin & Herb University
Vitamin Information Minerals Information Dietary Supplement Information Herb Information Drug Herb Interaction Continuing Education Pharmacy
Vitamin & Herb University
Molybdenum

Red Arrow  Facts Red Arrow  Functions
Red Arrow  Requirements & Recommendations Red Arrow  Deficiency signs and symptoms
Red Arrow  Toxicity Red Arrow  Dietary Sources
Red Arrow  Populations w/ Special Needs Red Arrow  Drug-Mineral Interaction
Red Arrow  Research Summary

Print this page Print this page
Contact an Expert Contact an Expert
Dosage Chart  Dosage Chart

Facts

  • Molybdenum is an essential trace element in humans and is required for enzyme activity as a cofactor.
  • Molybdenum is a transition element that can exist in multiple oxidation states and facilitate electron transfer in oxidation-reduction reactions.
  • Molybdenum in foods and as soluble complexes is readily absorbed. Copper can inhibit absorption in humans.
  • Under normal dietary conditions, molybdenum content of human tissue is quite low (0.1 to 1.0 mcg per gram wet weight). Liver, kidney, adrenal glands and bone contain the highest amounts of molybdenum.
  • After absorption, molybdenum is rapidly excreted through the kidney (90%) and smaller amounts are excreted in bile (10%).
  • In addition to the molybdenum cofactor, the other important form of molybdenum is molybdate. Evidence suggests that the molbydenum found in blood and urine exists mainly as the molybdate ion (MoO42).


  • Functions

    • Molybdenum functions mainly as an enzyme cofactor. Three molybdoenzymes catalyze hydroxylation of various substrates.
    • Aldehyde oxidase oxidizes and detoxifies various pyrimidines, purines, pteridines, and related compounds.
    • Xanthine oxidase/dehydrogenase catalyzes transformation of hypoxanthine to xanthine, and xanthine to uric acid.
    • Sulfite oxidase catalyzes the transformation of sulfite to sulfate. (Sulfite oxidase deficiency deranges cysteine metabolism).


  • Requirements & Recommendations

    Molybdenum: Dietary Reference Intake: 5
    mcg/day Tolerable
    Upper Intake Levels
    (UL)
    Infants
    0 to 6 months
    7 to 12 months
    2*
    3*
    ND
    ND
    Children
    1 to 3 years
    4 to 8 years
    17
    22
    300
    600
    Males
    9 to 13 years
    14 to 18 years
    19+ years
    Females
    9 to 13 years
    14 to 18 years
    19+ years
    34
    43
    45

    34
    43
    45
    1100
    1700
    2000

    1100
    1700
    2000
    Pregnancy
    <= 18 years
    19 to 50 years
    250
    50
    1700
    2000
    Lactation
    <= 18 years
    19 to 50 years
    50
    50
    1700
    2000


    Values are Adequate Intakes (AI).
    ND= Tolerable Upper Intake Levels (UL) are not determinable due to lack of data of adverse effects in this age group and concern with regard to lack of ability to handle excess amounts.


  • Deficiency signs and symptoms

    • Molybdenum deficiency is rare, unless the diet contains high amounts of the antagonistic substances such as, sulfate, copper or tungstate.
    • Signs of molybdenum deficiency are mouth and gum disorders, hypouricemia, hyperoxypurinemia, mental disturbance, and coma, as seen in patients with 'acquired molybdenum deficiency' resulting from parenteral methionine therapy.


  • Toxicity

    • Molybdenum is relatively non-toxic to humans.
    • Symptoms such as gout (inflammation of the joints due to accumulation of uric acid) are possible due to high blood uric acid concentrations and accumulation of uric acid around the joints. This occurs especially when molybdenum intakes exceed 10 to 15 mg daily.
    • Gout affects primarily males over the age of 40 and occasionally, postmenopausal women. One aspect of gout related to molybdenum is decreased uric acid excretion caused by molybdenum and sulfur binding to copper in the kidneys.


  • Dietary Sources

    Milk, milk products, legumes, organ meats, and cereals are good dietary sources of molybdenum. A diet high in processed foods may lead to a deficiency in molybdenum.


  • Populations w/ Special Needs

    There has been one recorded case of an apparent molybdenum deficiency occurring in a subject receiving total parenteral nutrition (TPN) for 18 months due to Crohn’s disease. 3


  • Drug-Mineral Interaction

    4 5 6
    • No health hazards or side effects are known.
    • Caution with pregnancy or nursing, consult physician before using.
    Information on the relationship between substances and disease is provided for general information, in order to convey a balanced review of the scientific literature. In many cases the relationship between a substance and a disease is tentative and additional research is needed to confirm such a relationship.


  • Research Summary

    Arthritis: Some earlier research in the Utano National Hospital in Japan was conducted on 60 patients undergoing long-term hemodialysis. Although serum molybdenum concentrations decreased significantly after hemodialysis, 9 patients with dialysis related arthritis had elevated serum molybdenum concentrations. Abnormal molybdenum accumulation may contribute to dialysis-related arthritis. 7




  • Reference box top left Reference header box help Reference box top right
    Reference box side
    Bullets Herbs (1 reference)
     View my references
    To save references
    you must be logged in.
    Click Here to log in.
    Reference box side
    Reference box bottom left Reference box side Reference box bottom right

    For more information, visit www.naturemade.com.